JD-5037
A selective, peripherally restricted cannabinoid-1 (CB1) receptor blocker with IC50 of 1.5 nM; shows no effect on CB2 (>10 uM) ; equieffective with its brain-penetrant parent compound in reducing appetite, body weight, hepatic steatosis, and insulin resistance, even though it does not occupy central CB1R or induce related behaviors.
Product Specifications
CAS Number
1392116-14-1
Product Name Alternative
JD 5037 | JD5037
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
CC (C) [C@@H] (C (N) =O) /N=C (N1N=C (C2=CC=C (Cl) C=C2) [C@@H] (C3=CC=CC=C3) C1) /NS (=O) (C4=CC=C (Cl) C=C4) =O
Molecular Formula
C27H27Cl2N5O3S
Molecular Weight
572.506
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Butanamide, 2-[[[ (4S) -3- (4-chlorophenyl) -4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[ (4-chlorophenyl) sulfonyl]amino]methylene]amino]-3-methyl-, (2S) -
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog